This is the v1 release of the datasets and code for the visuals in the manuscript:

Performance characteristics and potential public health impact of improved pre-erythrocytic malaria vaccines targeting childhood burden

Josephine Malinga,^1,2 Lydia Braunack-Mayer,^3,4 Thiery Masserey,^3,4 Aurélien Cavelan,⁴ Daniel Chandramohan,⁵ Alassane Dicko,⁶ Jean-Bosco Ouédraogo,⁷ Sherrie L Kelly,³ Epke A Le Rutte,^1,2 Narimane Nekkab,^3,4 Melissa A Penny^1,2,3,4*

¹ The Kids Research Institute, Nedlands, WA, Australia; ² Centre for Child Health Research, University of Western Australia, Crawley, WA, Australia; ³Swiss Tropical and Public Health Institute, Allschwil, Switzerland; ⁴University of Basel, Basel, Switzerland; ⁵London School of Hygiene and Tropical Medicine, London, United Kingdom; ⁶ Malaria Research and Training Centre, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali;  ⁷ Institut des Sciences et Techniques-Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso

*Correspondence to: Prof Melissa A Penny, University of Western Australia, Crawley, Australia

melissa.penny@uwa.edu.au

Using an individual-based malaria transmission model (https://github.com/SwissTPH/openmalaria/wiki) we evaluate the population level impact of deploying a long duration pre-erythrocytic vaccine, linking vaccine performance properties, health system and programmatic factors and understanding their trade-offs and relationships.